|
 | Up a level |
Salamat, JM and Abbott, KL and Gill, KS and Flannery, PC and Biancardi, VC and Boothe, DM and Huang, C-CJ and Mani, S and Chandran, A and Vishveshwara, S and Onteru, SK and Dhanasekaran, M and Pondugula, SR (2021) Insights into Mechanisms and Models for Studying Neurological Adverse Events Mediated by Pharmacokinetic Interactions between Clinical Drugs and Illicit Substances of Herbal and Fungal Origin. [Book Chapter]
Kumar, V and Ghosh, K and Chandran, A and Panwar, S and Bhat, A and Konaje, S and Das, S and Srikanta, S and Jaganathan, L and Prasad, S and Venkatesh, DB and Shivaram, C and Krishnaswamy, PR and Bhat, N (2021) Multicentric evaluation of a novel point of care electrochemical ELISA platform for SARS-CoV-2 specific IgG and IgM antibody assay. In: Journal of Virological Methods, 298 .
Kumar, V and Ghosh, K and Chandran, A and Panwar, S and Bhat, A and Konaje, S and Das, S and Srikanta, S and Jaganathan, L and Prasad, S and Venkatesh, DB and Shivaram, C and Swamy, PRK and Bhat, N (2021) Multicentric evaluation of a novel point of care electrochemical ELISA platform for SARS-CoV-2 specific IgG and IgM antibody assay. In: Journal of Virological Methods, 298 .
Prakash, MK and Kaushal, S and Bhattacharya, S and Chandran, A and Kumar, A and Ansumali, S (2020) Minimal and adaptive numerical strategy for critical resource planning in a pandemic. In: Physical Review E, 102 (2).
Abbott, KL and Chaudhury, CS and Chandran, A and Vishveshwara, S and Dvorak, Z and Jiskrova, E and Poulikova, K and Vyhlidalova, B and Mani, S and Pondugula, SR (2019) Belinostat, at its clinically relevant concentrations, inhibits rifampicin-induced CYP3A4 and MDR1 gene expressions. In: Molecular Pharmacology, 95 (3). pp. 324-334.
Jacob , KT and Chandran , A and Mallya , RM (2000) An assessment of the reduction potential of hydrogen plasma. In: Zeitschrift für Metallkunde, 91 (5). 401-405 .
